nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Melatonin—MT3—lung cancer	0.00858	0.467	CrCbGaD
Zolmitriptan—Sumatriptan—ABCG2—lung cancer	0.00243	0.132	CrCbGaD
Zolmitriptan—Eletriptan—CYP2A6—lung cancer	0.0022	0.12	CrCbGaD
Zolmitriptan—Almotriptan—CYP2E1—lung cancer	0.002	0.109	CrCbGaD
Zolmitriptan—Melatonin—CYP1A1—lung cancer	0.00133	0.0726	CrCbGaD
Zolmitriptan—Sumatriptan—ABCB1—lung cancer	0.00101	0.055	CrCbGaD
Zolmitriptan—Eletriptan—ABCB1—lung cancer	0.000818	0.0445	CrCbGaD
Zolmitriptan—Epistaxis—Methotrexate—lung cancer	0.000299	0.000374	CcSEcCtD
Zolmitriptan—Hypersensitivity—Irinotecan—lung cancer	0.000299	0.000374	CcSEcCtD
Zolmitriptan—Convulsion—Docetaxel—lung cancer	0.000298	0.000373	CcSEcCtD
Zolmitriptan—Paraesthesia—Paclitaxel—lung cancer	0.000297	0.000372	CcSEcCtD
Zolmitriptan—Hypertension—Docetaxel—lung cancer	0.000297	0.000372	CcSEcCtD
Zolmitriptan—Bronchitis—Doxorubicin—lung cancer	0.000296	0.000371	CcSEcCtD
Zolmitriptan—Dyspnoea—Paclitaxel—lung cancer	0.000295	0.00037	CcSEcCtD
Zolmitriptan—Somnolence—Paclitaxel—lung cancer	0.000294	0.000368	CcSEcCtD
Zolmitriptan—Decreased appetite—Etoposide—lung cancer	0.000293	0.000367	CcSEcCtD
Zolmitriptan—Myalgia—Docetaxel—lung cancer	0.000293	0.000366	CcSEcCtD
Zolmitriptan—Arthralgia—Docetaxel—lung cancer	0.000293	0.000366	CcSEcCtD
Zolmitriptan—Chest pain—Docetaxel—lung cancer	0.000293	0.000366	CcSEcCtD
Zolmitriptan—Nausea—Vinorelbine—lung cancer	0.000292	0.000366	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Etoposide—lung cancer	0.000291	0.000365	CcSEcCtD
Zolmitriptan—Dyspepsia—Paclitaxel—lung cancer	0.000291	0.000365	CcSEcCtD
Zolmitriptan—Body temperature increased—Cisplatin—lung cancer	0.000291	0.000365	CcSEcCtD
Zolmitriptan—Asthenia—Irinotecan—lung cancer	0.000291	0.000365	CcSEcCtD
Zolmitriptan—Constipation—Etoposide—lung cancer	0.000289	0.000361	CcSEcCtD
Zolmitriptan—Pain—Etoposide—lung cancer	0.000289	0.000361	CcSEcCtD
Zolmitriptan—Decreased appetite—Paclitaxel—lung cancer	0.000288	0.00036	CcSEcCtD
Zolmitriptan—Dry mouth—Docetaxel—lung cancer	0.000286	0.000358	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000286	0.000358	CcSEcCtD
Zolmitriptan—Pollakiuria—Doxorubicin—lung cancer	0.000284	0.000356	CcSEcCtD
Zolmitriptan—Asthenia—Gemcitabine—lung cancer	0.000284	0.000355	CcSEcCtD
Zolmitriptan—Pain—Paclitaxel—lung cancer	0.000283	0.000354	CcSEcCtD
Zolmitriptan—Constipation—Paclitaxel—lung cancer	0.000283	0.000354	CcSEcCtD
Zolmitriptan—Confusional state—Docetaxel—lung cancer	0.000283	0.000354	CcSEcCtD
Zolmitriptan—Pharyngitis—Methotrexate—lung cancer	0.000282	0.000354	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Methotrexate—lung cancer	0.000281	0.000352	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Doxorubicin—lung cancer	0.000281	0.000352	CcSEcCtD
Zolmitriptan—Oedema—Docetaxel—lung cancer	0.00028	0.000351	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Docetaxel—lung cancer	0.00028	0.000351	CcSEcCtD
Zolmitriptan—Weight increased—Doxorubicin—lung cancer	0.00028	0.000351	CcSEcCtD
Zolmitriptan—Pruritus—Gemcitabine—lung cancer	0.00028	0.00035	CcSEcCtD
Zolmitriptan—Urethral disorder—Methotrexate—lung cancer	0.000279	0.000349	CcSEcCtD
Zolmitriptan—Infection—Docetaxel—lung cancer	0.000279	0.000349	CcSEcCtD
Zolmitriptan—Feeling abnormal—Etoposide—lung cancer	0.000278	0.000348	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Doxorubicin—lung cancer	0.000278	0.000348	CcSEcCtD
Zolmitriptan—Diarrhoea—Irinotecan—lung cancer	0.000278	0.000348	CcSEcCtD
Zolmitriptan—Pneumonia—Doxorubicin—lung cancer	0.000276	0.000346	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Etoposide—lung cancer	0.000276	0.000346	CcSEcCtD
Zolmitriptan—Shock—Docetaxel—lung cancer	0.000276	0.000346	CcSEcCtD
Zolmitriptan—Nervous system disorder—Docetaxel—lung cancer	0.000275	0.000345	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Docetaxel—lung cancer	0.000275	0.000344	CcSEcCtD
Zolmitriptan—Tachycardia—Docetaxel—lung cancer	0.000274	0.000343	CcSEcCtD
Zolmitriptan—Feeling abnormal—Paclitaxel—lung cancer	0.000273	0.000342	CcSEcCtD
Zolmitriptan—Skin disorder—Docetaxel—lung cancer	0.000272	0.000341	CcSEcCtD
Zolmitriptan—Hypersensitivity—Cisplatin—lung cancer	0.000271	0.00034	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Paclitaxel—lung cancer	0.000271	0.000339	CcSEcCtD
Zolmitriptan—Diarrhoea—Gemcitabine—lung cancer	0.00027	0.000339	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Doxorubicin—lung cancer	0.000269	0.000337	CcSEcCtD
Zolmitriptan—Dizziness—Irinotecan—lung cancer	0.000268	0.000336	CcSEcCtD
Zolmitriptan—Urticaria—Etoposide—lung cancer	0.000268	0.000336	CcSEcCtD
Zolmitriptan—Stomatitis—Doxorubicin—lung cancer	0.000267	0.000335	CcSEcCtD
Zolmitriptan—Jaundice—Doxorubicin—lung cancer	0.000267	0.000335	CcSEcCtD
Zolmitriptan—Anorexia—Docetaxel—lung cancer	0.000267	0.000335	CcSEcCtD
Zolmitriptan—Body temperature increased—Etoposide—lung cancer	0.000267	0.000334	CcSEcCtD
Zolmitriptan—Abdominal pain—Etoposide—lung cancer	0.000267	0.000334	CcSEcCtD
Zolmitriptan—Conjunctivitis—Doxorubicin—lung cancer	0.000267	0.000334	CcSEcCtD
Zolmitriptan—Urinary tract infection—Doxorubicin—lung cancer	0.000267	0.000334	CcSEcCtD
Zolmitriptan—Tinnitus—Methotrexate—lung cancer	0.000265	0.000332	CcSEcCtD
Zolmitriptan—Asthenia—Cisplatin—lung cancer	0.000264	0.000331	CcSEcCtD
Zolmitriptan—Cardiac disorder—Methotrexate—lung cancer	0.000264	0.000331	CcSEcCtD
Zolmitriptan—Sweating—Doxorubicin—lung cancer	0.000263	0.00033	CcSEcCtD
Zolmitriptan—Urticaria—Paclitaxel—lung cancer	0.000263	0.000329	CcSEcCtD
Zolmitriptan—Haematuria—Doxorubicin—lung cancer	0.000262	0.000328	CcSEcCtD
Zolmitriptan—Abdominal pain—Paclitaxel—lung cancer	0.000262	0.000328	CcSEcCtD
Zolmitriptan—Body temperature increased—Paclitaxel—lung cancer	0.000262	0.000328	CcSEcCtD
Zolmitriptan—Epistaxis—Doxorubicin—lung cancer	0.000259	0.000324	CcSEcCtD
Zolmitriptan—Angiopathy—Methotrexate—lung cancer	0.000258	0.000323	CcSEcCtD
Zolmitriptan—Vomiting—Irinotecan—lung cancer	0.000258	0.000323	CcSEcCtD
Zolmitriptan—Sinusitis—Doxorubicin—lung cancer	0.000257	0.000323	CcSEcCtD
Zolmitriptan—Immune system disorder—Methotrexate—lung cancer	0.000257	0.000322	CcSEcCtD
Zolmitriptan—Rash—Irinotecan—lung cancer	0.000256	0.00032	CcSEcCtD
Zolmitriptan—Dermatitis—Irinotecan—lung cancer	0.000256	0.00032	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000256	0.00032	CcSEcCtD
Zolmitriptan—Chills—Methotrexate—lung cancer	0.000255	0.00032	CcSEcCtD
Zolmitriptan—Headache—Irinotecan—lung cancer	0.000254	0.000318	CcSEcCtD
Zolmitriptan—Insomnia—Docetaxel—lung cancer	0.000254	0.000318	CcSEcCtD
Zolmitriptan—Diarrhoea—Cisplatin—lung cancer	0.000252	0.000316	CcSEcCtD
Zolmitriptan—Paraesthesia—Docetaxel—lung cancer	0.000252	0.000315	CcSEcCtD
Zolmitriptan—Vomiting—Gemcitabine—lung cancer	0.000251	0.000315	CcSEcCtD
Zolmitriptan—Bradycardia—Doxorubicin—lung cancer	0.000251	0.000314	CcSEcCtD
Zolmitriptan—Dyspnoea—Docetaxel—lung cancer	0.00025	0.000313	CcSEcCtD
Zolmitriptan—Somnolence—Docetaxel—lung cancer	0.000249	0.000312	CcSEcCtD
Zolmitriptan—Rash—Gemcitabine—lung cancer	0.000249	0.000312	CcSEcCtD
Zolmitriptan—Dermatitis—Gemcitabine—lung cancer	0.000249	0.000312	CcSEcCtD
Zolmitriptan—Hypersensitivity—Etoposide—lung cancer	0.000249	0.000311	CcSEcCtD
Zolmitriptan—Erythema—Methotrexate—lung cancer	0.000248	0.00031	CcSEcCtD
Zolmitriptan—Headache—Gemcitabine—lung cancer	0.000248	0.00031	CcSEcCtD
Zolmitriptan—Rhinitis—Doxorubicin—lung cancer	0.000247	0.000309	CcSEcCtD
Zolmitriptan—Dyspepsia—Docetaxel—lung cancer	0.000247	0.000309	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Doxorubicin—lung cancer	0.000245	0.000307	CcSEcCtD
Zolmitriptan—Pharyngitis—Doxorubicin—lung cancer	0.000245	0.000306	CcSEcCtD
Zolmitriptan—Decreased appetite—Docetaxel—lung cancer	0.000244	0.000305	CcSEcCtD
Zolmitriptan—Hypersensitivity—Paclitaxel—lung cancer	0.000244	0.000305	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Doxorubicin—lung cancer	0.000243	0.000305	CcSEcCtD
Zolmitriptan—Oedema peripheral—Doxorubicin—lung cancer	0.000243	0.000304	CcSEcCtD
Zolmitriptan—Dysgeusia—Methotrexate—lung cancer	0.000243	0.000304	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Docetaxel—lung cancer	0.000242	0.000303	CcSEcCtD
Zolmitriptan—Asthenia—Etoposide—lung cancer	0.000242	0.000303	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Doxorubicin—lung cancer	0.000242	0.000303	CcSEcCtD
Zolmitriptan—Urethral disorder—Doxorubicin—lung cancer	0.000241	0.000303	CcSEcCtD
Zolmitriptan—Nausea—Irinotecan—lung cancer	0.000241	0.000302	CcSEcCtD
Zolmitriptan—Constipation—Docetaxel—lung cancer	0.00024	0.0003	CcSEcCtD
Zolmitriptan—Pain—Docetaxel—lung cancer	0.00024	0.0003	CcSEcCtD
Zolmitriptan—Back pain—Methotrexate—lung cancer	0.00024	0.0003	CcSEcCtD
Zolmitriptan—Pruritus—Etoposide—lung cancer	0.000239	0.000299	CcSEcCtD
Zolmitriptan—Asthenia—Paclitaxel—lung cancer	0.000237	0.000297	CcSEcCtD
Zolmitriptan—Nausea—Gemcitabine—lung cancer	0.000235	0.000294	CcSEcCtD
Zolmitriptan—Vomiting—Cisplatin—lung cancer	0.000234	0.000293	CcSEcCtD
Zolmitriptan—Pruritus—Paclitaxel—lung cancer	0.000234	0.000293	CcSEcCtD
Zolmitriptan—Rash—Cisplatin—lung cancer	0.000232	0.000291	CcSEcCtD
Zolmitriptan—Dermatitis—Cisplatin—lung cancer	0.000232	0.000291	CcSEcCtD
Zolmitriptan—Feeling abnormal—Docetaxel—lung cancer	0.000231	0.000289	CcSEcCtD
Zolmitriptan—Diarrhoea—Etoposide—lung cancer	0.000231	0.000289	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Methotrexate—lung cancer	0.00023	0.000288	CcSEcCtD
Zolmitriptan—Tinnitus—Doxorubicin—lung cancer	0.00023	0.000288	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Docetaxel—lung cancer	0.000229	0.000287	CcSEcCtD
Zolmitriptan—Cardiac disorder—Doxorubicin—lung cancer	0.000229	0.000286	CcSEcCtD
Zolmitriptan—Diarrhoea—Paclitaxel—lung cancer	0.000226	0.000284	CcSEcCtD
Zolmitriptan—Angiopathy—Doxorubicin—lung cancer	0.000224	0.00028	CcSEcCtD
Zolmitriptan—Malaise—Methotrexate—lung cancer	0.000223	0.00028	CcSEcCtD
Zolmitriptan—Dizziness—Etoposide—lung cancer	0.000223	0.00028	CcSEcCtD
Zolmitriptan—Immune system disorder—Doxorubicin—lung cancer	0.000223	0.000279	CcSEcCtD
Zolmitriptan—Vertigo—Methotrexate—lung cancer	0.000223	0.000279	CcSEcCtD
Zolmitriptan—Abdominal pain—Docetaxel—lung cancer	0.000222	0.000278	CcSEcCtD
Zolmitriptan—Body temperature increased—Docetaxel—lung cancer	0.000222	0.000278	CcSEcCtD
Zolmitriptan—Leukopenia—Methotrexate—lung cancer	0.000222	0.000278	CcSEcCtD
Zolmitriptan—Chills—Doxorubicin—lung cancer	0.000221	0.000277	CcSEcCtD
Zolmitriptan—Arrhythmia—Doxorubicin—lung cancer	0.00022	0.000276	CcSEcCtD
Zolmitriptan—Dizziness—Paclitaxel—lung cancer	0.000219	0.000274	CcSEcCtD
Zolmitriptan—Nausea—Cisplatin—lung cancer	0.000219	0.000274	CcSEcCtD
Zolmitriptan—Cough—Methotrexate—lung cancer	0.000216	0.000271	CcSEcCtD
Zolmitriptan—Convulsion—Methotrexate—lung cancer	0.000215	0.000269	CcSEcCtD
Zolmitriptan—Vomiting—Etoposide—lung cancer	0.000215	0.000269	CcSEcCtD
Zolmitriptan—Erythema—Doxorubicin—lung cancer	0.000214	0.000269	CcSEcCtD
Zolmitriptan—Rash—Etoposide—lung cancer	0.000213	0.000267	CcSEcCtD
Zolmitriptan—Dermatitis—Etoposide—lung cancer	0.000213	0.000266	CcSEcCtD
Zolmitriptan—Headache—Etoposide—lung cancer	0.000211	0.000265	CcSEcCtD
Zolmitriptan—Myalgia—Methotrexate—lung cancer	0.000211	0.000264	CcSEcCtD
Zolmitriptan—Chest pain—Methotrexate—lung cancer	0.000211	0.000264	CcSEcCtD
Zolmitriptan—Arthralgia—Methotrexate—lung cancer	0.000211	0.000264	CcSEcCtD
Zolmitriptan—Tension—Doxorubicin—lung cancer	0.00021	0.000264	CcSEcCtD
Zolmitriptan—Vomiting—Paclitaxel—lung cancer	0.00021	0.000264	CcSEcCtD
Zolmitriptan—Dysgeusia—Doxorubicin—lung cancer	0.00021	0.000263	CcSEcCtD
Zolmitriptan—Rash—Paclitaxel—lung cancer	0.000209	0.000261	CcSEcCtD
Zolmitriptan—Dermatitis—Paclitaxel—lung cancer	0.000208	0.000261	CcSEcCtD
Zolmitriptan—Discomfort—Methotrexate—lung cancer	0.000208	0.000261	CcSEcCtD
Zolmitriptan—Nervousness—Doxorubicin—lung cancer	0.000208	0.000261	CcSEcCtD
Zolmitriptan—Back pain—Doxorubicin—lung cancer	0.000207	0.00026	CcSEcCtD
Zolmitriptan—Headache—Paclitaxel—lung cancer	0.000207	0.00026	CcSEcCtD
Zolmitriptan—Hypersensitivity—Docetaxel—lung cancer	0.000207	0.000259	CcSEcCtD
Zolmitriptan—Muscle spasms—Doxorubicin—lung cancer	0.000206	0.000258	CcSEcCtD
Zolmitriptan—Confusional state—Methotrexate—lung cancer	0.000204	0.000255	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Methotrexate—lung cancer	0.000202	0.000253	CcSEcCtD
Zolmitriptan—Asthenia—Docetaxel—lung cancer	0.000201	0.000252	CcSEcCtD
Zolmitriptan—Infection—Methotrexate—lung cancer	0.000201	0.000252	CcSEcCtD
Zolmitriptan—Nausea—Etoposide—lung cancer	0.0002	0.000251	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Doxorubicin—lung cancer	0.000199	0.000249	CcSEcCtD
Zolmitriptan—Pruritus—Docetaxel—lung cancer	0.000198	0.000249	CcSEcCtD
Zolmitriptan—Nervous system disorder—Methotrexate—lung cancer	0.000198	0.000248	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Methotrexate—lung cancer	0.000198	0.000248	CcSEcCtD
Zolmitriptan—Agitation—Doxorubicin—lung cancer	0.000197	0.000247	CcSEcCtD
Zolmitriptan—Nausea—Paclitaxel—lung cancer	0.000197	0.000246	CcSEcCtD
Zolmitriptan—Skin disorder—Methotrexate—lung cancer	0.000196	0.000246	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Methotrexate—lung cancer	0.000195	0.000245	CcSEcCtD
Zolmitriptan—Malaise—Doxorubicin—lung cancer	0.000193	0.000242	CcSEcCtD
Zolmitriptan—Vertigo—Doxorubicin—lung cancer	0.000193	0.000241	CcSEcCtD
Zolmitriptan—Anorexia—Methotrexate—lung cancer	0.000193	0.000241	CcSEcCtD
Zolmitriptan—Syncope—Doxorubicin—lung cancer	0.000192	0.000241	CcSEcCtD
Zolmitriptan—Leukopenia—Doxorubicin—lung cancer	0.000192	0.00024	CcSEcCtD
Zolmitriptan—Diarrhoea—Docetaxel—lung cancer	0.000192	0.00024	CcSEcCtD
Zolmitriptan—Palpitations—Doxorubicin—lung cancer	0.00019	0.000237	CcSEcCtD
Zolmitriptan—Loss of consciousness—Doxorubicin—lung cancer	0.000188	0.000236	CcSEcCtD
Zolmitriptan—Cough—Doxorubicin—lung cancer	0.000187	0.000234	CcSEcCtD
Zolmitriptan—Convulsion—Doxorubicin—lung cancer	0.000186	0.000233	CcSEcCtD
Zolmitriptan—Dizziness—Docetaxel—lung cancer	0.000185	0.000232	CcSEcCtD
Zolmitriptan—Hypertension—Doxorubicin—lung cancer	0.000185	0.000232	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000184	0.000231	CcSEcCtD
Zolmitriptan—Insomnia—Methotrexate—lung cancer	0.000183	0.000229	CcSEcCtD
Zolmitriptan—Myalgia—Doxorubicin—lung cancer	0.000183	0.000229	CcSEcCtD
Zolmitriptan—Chest pain—Doxorubicin—lung cancer	0.000183	0.000229	CcSEcCtD
Zolmitriptan—Arthralgia—Doxorubicin—lung cancer	0.000183	0.000229	CcSEcCtD
Zolmitriptan—Anxiety—Doxorubicin—lung cancer	0.000182	0.000228	CcSEcCtD
Zolmitriptan—Paraesthesia—Methotrexate—lung cancer	0.000182	0.000227	CcSEcCtD
Zolmitriptan—Discomfort—Doxorubicin—lung cancer	0.00018	0.000226	CcSEcCtD
Zolmitriptan—Dyspnoea—Methotrexate—lung cancer	0.00018	0.000226	CcSEcCtD
Zolmitriptan—Somnolence—Methotrexate—lung cancer	0.00018	0.000225	CcSEcCtD
Zolmitriptan—Dry mouth—Doxorubicin—lung cancer	0.000179	0.000224	CcSEcCtD
Zolmitriptan—Vomiting—Docetaxel—lung cancer	0.000178	0.000223	CcSEcCtD
Zolmitriptan—Dyspepsia—Methotrexate—lung cancer	0.000178	0.000223	CcSEcCtD
Zolmitriptan—Rash—Docetaxel—lung cancer	0.000177	0.000222	CcSEcCtD
Zolmitriptan—Dermatitis—Docetaxel—lung cancer	0.000177	0.000221	CcSEcCtD
Zolmitriptan—Confusional state—Doxorubicin—lung cancer	0.000176	0.000221	CcSEcCtD
Zolmitriptan—Decreased appetite—Methotrexate—lung cancer	0.000176	0.00022	CcSEcCtD
Zolmitriptan—Headache—Docetaxel—lung cancer	0.000176	0.00022	CcSEcCtD
Zolmitriptan—Oedema—Doxorubicin—lung cancer	0.000175	0.000219	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Doxorubicin—lung cancer	0.000175	0.000219	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Methotrexate—lung cancer	0.000175	0.000219	CcSEcCtD
Zolmitriptan—Infection—Doxorubicin—lung cancer	0.000174	0.000218	CcSEcCtD
Zolmitriptan—Pain—Methotrexate—lung cancer	0.000173	0.000217	CcSEcCtD
Zolmitriptan—Shock—Doxorubicin—lung cancer	0.000172	0.000216	CcSEcCtD
Zolmitriptan—Nervous system disorder—Doxorubicin—lung cancer	0.000172	0.000215	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Doxorubicin—lung cancer	0.000171	0.000215	CcSEcCtD
Zolmitriptan—Tachycardia—Doxorubicin—lung cancer	0.000171	0.000214	CcSEcCtD
Zolmitriptan—Skin disorder—Doxorubicin—lung cancer	0.00017	0.000213	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Doxorubicin—lung cancer	0.000169	0.000212	CcSEcCtD
Zolmitriptan—Anorexia—Doxorubicin—lung cancer	0.000167	0.000209	CcSEcCtD
Zolmitriptan—Nausea—Docetaxel—lung cancer	0.000167	0.000209	CcSEcCtD
Zolmitriptan—Feeling abnormal—Methotrexate—lung cancer	0.000167	0.000209	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Methotrexate—lung cancer	0.000165	0.000207	CcSEcCtD
Zolmitriptan—Urticaria—Methotrexate—lung cancer	0.000161	0.000201	CcSEcCtD
Zolmitriptan—Abdominal pain—Methotrexate—lung cancer	0.00016	0.0002	CcSEcCtD
Zolmitriptan—Body temperature increased—Methotrexate—lung cancer	0.00016	0.0002	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000159	0.0002	CcSEcCtD
Zolmitriptan—Insomnia—Doxorubicin—lung cancer	0.000158	0.000198	CcSEcCtD
Zolmitriptan—Paraesthesia—Doxorubicin—lung cancer	0.000157	0.000197	CcSEcCtD
Zolmitriptan—Dyspnoea—Doxorubicin—lung cancer	0.000156	0.000195	CcSEcCtD
Zolmitriptan—Somnolence—Doxorubicin—lung cancer	0.000156	0.000195	CcSEcCtD
Zolmitriptan—Dyspepsia—Doxorubicin—lung cancer	0.000154	0.000193	CcSEcCtD
Zolmitriptan—Decreased appetite—Doxorubicin—lung cancer	0.000152	0.000191	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000151	0.000189	CcSEcCtD
Zolmitriptan—Constipation—Doxorubicin—lung cancer	0.00015	0.000187	CcSEcCtD
Zolmitriptan—Pain—Doxorubicin—lung cancer	0.00015	0.000187	CcSEcCtD
Zolmitriptan—Hypersensitivity—Methotrexate—lung cancer	0.000149	0.000187	CcSEcCtD
Zolmitriptan—Asthenia—Methotrexate—lung cancer	0.000145	0.000182	CcSEcCtD
Zolmitriptan—Feeling abnormal—Doxorubicin—lung cancer	0.000144	0.000181	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Doxorubicin—lung cancer	0.000143	0.000179	CcSEcCtD
Zolmitriptan—Pruritus—Methotrexate—lung cancer	0.000143	0.000179	CcSEcCtD
Zolmitriptan—Urticaria—Doxorubicin—lung cancer	0.000139	0.000174	CcSEcCtD
Zolmitriptan—Abdominal pain—Doxorubicin—lung cancer	0.000138	0.000173	CcSEcCtD
Zolmitriptan—Body temperature increased—Doxorubicin—lung cancer	0.000138	0.000173	CcSEcCtD
Zolmitriptan—Diarrhoea—Methotrexate—lung cancer	0.000138	0.000173	CcSEcCtD
Zolmitriptan—Dizziness—Methotrexate—lung cancer	0.000134	0.000167	CcSEcCtD
Zolmitriptan—Hypersensitivity—Doxorubicin—lung cancer	0.000129	0.000162	CcSEcCtD
Zolmitriptan—Vomiting—Methotrexate—lung cancer	0.000129	0.000161	CcSEcCtD
Zolmitriptan—Rash—Methotrexate—lung cancer	0.000127	0.00016	CcSEcCtD
Zolmitriptan—Dermatitis—Methotrexate—lung cancer	0.000127	0.000159	CcSEcCtD
Zolmitriptan—Headache—Methotrexate—lung cancer	0.000127	0.000159	CcSEcCtD
Zolmitriptan—Asthenia—Doxorubicin—lung cancer	0.000126	0.000157	CcSEcCtD
Zolmitriptan—Pruritus—Doxorubicin—lung cancer	0.000124	0.000155	CcSEcCtD
Zolmitriptan—Nausea—Methotrexate—lung cancer	0.00012	0.00015	CcSEcCtD
Zolmitriptan—Diarrhoea—Doxorubicin—lung cancer	0.00012	0.00015	CcSEcCtD
Zolmitriptan—Dizziness—Doxorubicin—lung cancer	0.000116	0.000145	CcSEcCtD
Zolmitriptan—Vomiting—Doxorubicin—lung cancer	0.000111	0.000139	CcSEcCtD
Zolmitriptan—Rash—Doxorubicin—lung cancer	0.00011	0.000138	CcSEcCtD
Zolmitriptan—Dermatitis—Doxorubicin—lung cancer	0.00011	0.000138	CcSEcCtD
Zolmitriptan—Headache—Doxorubicin—lung cancer	0.00011	0.000137	CcSEcCtD
Zolmitriptan—Nausea—Doxorubicin—lung cancer	0.000104	0.00013	CcSEcCtD
Zolmitriptan—HTR1A—Signaling by GPCR—MAP2K1—lung cancer	4.24e-05	0.000231	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—lung cancer	4.22e-05	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—lung cancer	4.21e-05	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CD—lung cancer	4.21e-05	0.00023	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.21e-05	0.000229	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTA2—lung cancer	4.19e-05	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—lung cancer	4.18e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2—lung cancer	4.17e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOA1—lung cancer	4.15e-05	0.000226	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—lung cancer	4.15e-05	0.000226	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—lung cancer	4.11e-05	0.000224	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCND1—lung cancer	4.07e-05	0.000222	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOA1—lung cancer	4.07e-05	0.000222	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—JUN—lung cancer	4.06e-05	0.000221	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AVP—lung cancer	4.05e-05	0.000221	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTA1—lung cancer	4.05e-05	0.000221	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CB—lung cancer	4.04e-05	0.00022	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—lung cancer	4.03e-05	0.00022	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCC3—lung cancer	4e-05	0.000218	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CG—lung cancer	3.98e-05	0.000217	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—lung cancer	3.95e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1A—lung cancer	3.93e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTEN—lung cancer	3.92e-05	0.000214	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1R—lung cancer	3.9e-05	0.000213	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—lung cancer	3.88e-05	0.000212	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKR1C1—lung cancer	3.87e-05	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HES1—lung cancer	3.83e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—lung cancer	3.83e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CG—lung cancer	3.79e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KIT—lung cancer	3.79e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APC—lung cancer	3.79e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—NRAS—lung cancer	3.79e-05	0.000207	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—POMC—lung cancer	3.79e-05	0.000207	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—UGT1A1—lung cancer	3.76e-05	0.000205	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RAF1—lung cancer	3.76e-05	0.000205	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGF—lung cancer	3.75e-05	0.000204	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EP300—lung cancer	3.74e-05	0.000204	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APC—lung cancer	3.71e-05	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CG—lung cancer	3.71e-05	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KIT—lung cancer	3.71e-05	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—NRAS—lung cancer	3.71e-05	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—lung cancer	3.71e-05	0.000202	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CREBBP—lung cancer	3.69e-05	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGF—lung cancer	3.67e-05	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CB—lung cancer	3.67e-05	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SRC—lung cancer	3.64e-05	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK3—lung cancer	3.63e-05	0.000198	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNG11—lung cancer	3.63e-05	0.000198	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.61e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—POMC—lung cancer	3.61e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—lung cancer	3.56e-05	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK3—lung cancer	3.55e-05	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—lung cancer	3.54e-05	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—POMC—lung cancer	3.53e-05	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—lung cancer	3.52e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6R—lung cancer	3.52e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CREBBP—lung cancer	3.51e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—lung cancer	3.51e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NRAS—lung cancer	3.5e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB3—lung cancer	3.5e-05	0.000191	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CD—lung cancer	3.5e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—lung cancer	3.49e-05	0.00019	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—lung cancer	3.45e-05	0.000188	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDOA—lung cancer	3.45e-05	0.000188	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—lung cancer	3.45e-05	0.000188	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6R—lung cancer	3.45e-05	0.000188	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CREBBP—lung cancer	3.44e-05	0.000188	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—lung cancer	3.38e-05	0.000184	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—lung cancer	3.37e-05	0.000184	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TERT—lung cancer	3.36e-05	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAP2K1—lung cancer	3.35e-05	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK3—lung cancer	3.35e-05	0.000183	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NCOA3—lung cancer	3.35e-05	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CD—lung cancer	3.33e-05	0.000182	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—lung cancer	3.3e-05	0.00018	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.29e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAP2K1—lung cancer	3.28e-05	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CD—lung cancer	3.26e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KRAS—lung cancer	3.26e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—lung cancer	3.26e-05	0.000178	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADCY1—lung cancer	3.26e-05	0.000178	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCG2—lung cancer	3.26e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGFR1—lung cancer	3.26e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—lung cancer	3.23e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—lung cancer	3.21e-05	0.000175	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO2—lung cancer	3.2e-05	0.000174	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HPGDS—lung cancer	3.2e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KRAS—lung cancer	3.19e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—lung cancer	3.19e-05	0.000174	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPP2R1B—lung cancer	3.18e-05	0.000173	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.14e-05	0.000171	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—lung cancer	3.1e-05	0.000169	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOA1—lung cancer	3.1e-05	0.000169	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—lung cancer	3.07e-05	0.000167	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCLC—lung cancer	3.07e-05	0.000167	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2A6—lung cancer	3.07e-05	0.000167	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.05e-05	0.000167	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CB—lung cancer	3.05e-05	0.000166	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—lung cancer	3.02e-05	0.000165	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KRAS—lung cancer	3.01e-05	0.000164	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—lung cancer	3e-05	0.000163	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MDM2—lung cancer	2.99e-05	0.000163	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAF1—lung cancer	2.97e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ERBB2—lung cancer	2.94e-05	0.000161	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—lung cancer	2.93e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MDM2—lung cancer	2.92e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAF1—lung cancer	2.91e-05	0.000159	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO1—lung cancer	2.91e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MTOR—lung cancer	2.9e-05	0.000158	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CB—lung cancer	2.9e-05	0.000158	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.9e-05	0.000158	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ERBB2—lung cancer	2.88e-05	0.000157	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.86e-05	0.000156	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CB—lung cancer	2.84e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MTOR—lung cancer	2.84e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KIT—lung cancer	2.83e-05	0.000154	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APC—lung cancer	2.83e-05	0.000154	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CG—lung cancer	2.83e-05	0.000154	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—NRAS—lung cancer	2.83e-05	0.000154	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGF—lung cancer	2.79e-05	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—lung cancer	2.79e-05	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HRAS—lung cancer	2.77e-05	0.000151	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—lung cancer	2.77e-05	0.000151	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—lung cancer	2.73e-05	0.000149	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HRAS—lung cancer	2.72e-05	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK3—lung cancer	2.71e-05	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—lung cancer	2.7e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—POMC—lung cancer	2.69e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—lung cancer	2.68e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—lung cancer	2.67e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—lung cancer	2.67e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—lung cancer	2.66e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—lung cancer	2.65e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—lung cancer	2.64e-05	0.000144	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTEN—lung cancer	2.63e-05	0.000144	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6R—lung cancer	2.63e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CREBBP—lung cancer	2.62e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—lung cancer	2.62e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—lung cancer	2.61e-05	0.000142	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2E1—lung cancer	2.61e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—lung cancer	2.6e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—lung cancer	2.6e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUN—lung cancer	2.59e-05	0.000142	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NQO1—lung cancer	2.58e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—lung cancer	2.58e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HRAS—lung cancer	2.56e-05	0.00014	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—lung cancer	2.55e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUN—lung cancer	2.54e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—lung cancer	2.52e-05	0.000138	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.52e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1A—lung cancer	2.52e-05	0.000137	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—EP300—lung cancer	2.51e-05	0.000137	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTEN—lung cancer	2.51e-05	0.000137	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAP2K1—lung cancer	2.5e-05	0.000136	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.5e-05	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CD—lung cancer	2.49e-05	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—lung cancer	2.47e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1A—lung cancer	2.46e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	2.46e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTEN—lung cancer	2.46e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—lung cancer	2.45e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—lung cancer	2.45e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KRAS—lung cancer	2.43e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—lung cancer	2.4e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EP300—lung cancer	2.39e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EP300—lung cancer	2.34e-05	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SRC—lung cancer	2.33e-05	0.000127	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—STK11—lung cancer	2.32e-05	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SRC—lung cancer	2.28e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—lung cancer	2.27e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—lung cancer	2.26e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—lung cancer	2.24e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NRAS—lung cancer	2.24e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	2.24e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MDM2—lung cancer	2.23e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—lung cancer	2.22e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAF1—lung cancer	2.22e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—lung cancer	2.2e-05	0.00012	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB2—lung cancer	2.2e-05	0.00012	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NRAS—lung cancer	2.19e-05	0.00012	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.18e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MTOR—lung cancer	2.17e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CB—lung cancer	2.17e-05	0.000118	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—lung cancer	2.15e-05	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK3—lung cancer	2.14e-05	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK3—lung cancer	2.1e-05	0.000115	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAT—lung cancer	2.09e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—lung cancer	2.09e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—lung cancer	2.08e-05	0.000114	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.08e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HRAS—lung cancer	2.07e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—lung cancer	2.04e-05	0.000111	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—lung cancer	2.04e-05	0.000111	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—lung cancer	2.04e-05	0.000111	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—lung cancer	2.01e-05	0.00011	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TYMS—lung cancer	2e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—lung cancer	2e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—lung cancer	1.99e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—lung cancer	1.99e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—lung cancer	1.98e-05	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—lung cancer	1.98e-05	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—lung cancer	1.94e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUN—lung cancer	1.94e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KRAS—lung cancer	1.93e-05	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KRAS—lung cancer	1.89e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—lung cancer	1.88e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1A—lung cancer	1.88e-05	0.000102	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1A1—lung cancer	1.87e-05	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTEN—lung cancer	1.87e-05	0.000102	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—lung cancer	1.86e-05	0.000101	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ERCC2—lung cancer	1.86e-05	0.000101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.83e-05	9.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EP300—lung cancer	1.79e-05	9.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—lung cancer	1.77e-05	9.66e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SRC—lung cancer	1.74e-05	9.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—lung cancer	1.73e-05	9.46e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—lung cancer	1.71e-05	9.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.69e-05	9.22e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—lung cancer	1.68e-05	9.15e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—lung cancer	1.67e-05	9.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NRAS—lung cancer	1.67e-05	9.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HRAS—lung cancer	1.64e-05	8.94e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA1—lung cancer	1.61e-05	8.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HRAS—lung cancer	1.6e-05	8.75e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.6e-05	8.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—lung cancer	1.57e-05	8.55e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—lung cancer	1.56e-05	8.49e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.54e-05	8.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—lung cancer	1.54e-05	8.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—lung cancer	1.52e-05	8.3e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—lung cancer	1.52e-05	8.28e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CG—lung cancer	1.47e-05	8e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—lung cancer	1.45e-05	7.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KRAS—lung cancer	1.44e-05	7.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—lung cancer	1.42e-05	7.73e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—POMC—lung cancer	1.4e-05	7.62e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CREBBP—lung cancer	1.36e-05	7.42e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.32e-05	7.2e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CD—lung cancer	1.29e-05	7.03e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—lung cancer	1.28e-05	6.97e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—lung cancer	1.27e-05	6.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HRAS—lung cancer	1.22e-05	6.67e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—lung cancer	1.17e-05	6.38e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CB—lung cancer	1.12e-05	6.13e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—lung cancer	1.11e-05	6.08e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—lung cancer	1.08e-05	5.89e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTEN—lung cancer	9.71e-06	5.3e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—EP300—lung cancer	9.26e-06	5.05e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—lung cancer	6.85e-06	3.74e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—lung cancer	5.6e-06	3.05e-05	CbGpPWpGaD
